ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2469

Radiographic Sacroiliitis Progression In An Early Spondyloarthritis Cohort

Concepcion Castillo-Gallego1, Eugenio de Miguel2, Carmen Martin-Hervas3, Diana Peiteado1, Leticia Lojo4 and Emilio Martin-Mola5, 1Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, 2Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, 3Radiology, Hospital Universitario La Paz, Madrid, Spain, 4Rheumatology, Hospital Universitario La Paz, Spain, Spain, 5Rheumatology, Hospital Universitario La Paz, Madrid, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: radiography and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose:  

The improvement of treatment in axial Spondyloarthritis (axSpA) and the development of the ASAS classification criteria have facilitated the early diagnosis and management of this disease. It is important to know what are the more relevant predictors of radiographic progression in early SpA to take clinical decision.

 The aim of this study was to assess predictive factors for radiographic sacroiliitis progression in a cohort of early axSpA.

Methods:

Patients included in the study came from the early SpA unit at our hospital, as part of the ESPERANZA programme, a nationwide health management programme designed to provide excellence in care for early SpA. One of the inclusion criteria was symptom duration between 3 and 24 months. Every patient had a complete examination at baseline that included ESR, CRP, ASDAS-CRP, ASDAS-ESR, BASDAI, HLA-B27, radiographs of pelvis and Magnetic resonance (MRI) of sacroiliac joints (SIJ).  MRI of SIJ were assessed according to ASAS definition for bone marrow oedema. Radiographs of pelvis at baseline and at follow up were done for every patient. These x-Rays were centrally digitized and the SIJ were scored according to the grading system of the modified New York criteria (mNYc). SPSS program version 17.0 was used for Statistical analysis. Paired-sample t test was used for comparison of radiographic sacroiliitis progression.

Results:

Forty-one consecutive patients from the early axial Spondyloarhtritis cohort of the Esperanza program were analyzed, 39% of them were female. The average evolution time since onset of symptoms until baseline clinic visit was 10.9±7.1 months. All patients fulfilled ASAS criteria for axSpA and three of them had Ankylosing Spondytitis (AS) according to mNYc at baseline. The mean follow up time was 3.51 years (range: 2-5years; SD±1.03). Progression of sacroiliitis over follow up by at least one grade at one side was found in 61% (25/41). Among the 38 non radiographic axSpA patients at baseline, 5 of them (13.16%) progressed to AS according to mNYc. Statistically significant radiographic progression was observed in all the variables analyzed (see table 1).

Table 1:

 

Baseline   SIJ x-Ray score (mean±SD)

Follow up SIJ x-Ray score (mean±SD)

P

n

HLA-B27   positive

0.84±0.91

1.48±1.07

<0.001

23

HLA-B27   negative

0.25±0.55

0.58±0.73

<0.01

18

BASDAI<4

0.57±0.96

1.18±1.06

<0.001

14

BASDAI≥4

0.56±0.75

1.04±1.04

<0.001

26

CRP<5

0.47±0.75

0.97±0.90

<0.001

30

CRP≥5

0.82±0.96

1.41±1.30

<0.01

11

ESR<10

0.50±0.78

1.03±0.92

<0.001

29

ESR≥10

0.71±0.91

1.21±1.28

<0.01

12

ASDAS-CRP<2.1

0.35±0.73

0.76±0.85

<0.01

17

ASDAS-CRP≥2.1

0.72±0.86

1.33±1.12

<0.001

23

ASDAS-CRP<3.5

0.53±0.82

1.00±0.94

<0.001

31

ASDAS-CRP≥3.5

0.67±0.84

1.39±1.33

<0.01

8

ASDAS-ESR<2.1

0.34±0.70

0.69±0.82

<0.01

16

ASDAS-ESR≥2.1

0.71±0.87

1.35±1.10

<0.001

24

ASDAS-ESR<3.5

0.50±0.78

0.95±0.88

<0.001

31

ASDAS-ESR≥3.5

0.78±0.94

1.55±1.42

<0.01

9

MRI   positive

1.11±0.92

1.58±0.99

<0.001

14

MRI   negative

0.17±0.38

0.67±0.73

<0.001

20

Conclusion:

Every patient of this early axSpA cohort had radiographic sacroiliitis progression independently of the outcome assessed. Patients HLA-B27 positive, with MRI positive, higher values of CRP or ESR and higher scores of BASDAI and ASDAS not only presented higher  radiographic scores at baseline and but also more radiographic progression at follow up.


Disclosure:

C. Castillo-Gallego,
None;

E. de Miguel,
None;

C. Martin-Hervas,
None;

D. Peiteado,
None;

L. Lojo,
None;

E. Martin-Mola,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/radiographic-sacroiliitis-progression-in-an-early-spondyloarthritis-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology